The Beacon Hill FYI
House  ·  Senate  ·  Committees  ·  The data

An Act relative to opioid drug manufacturer assessments

Filed by Claire D. Cronin  ·  21 cosponsors  ·  191st General Court  ·  the legislature's own page

H1703  ·  Bill  ·  docket HD2699

4 actions

In the order the legislature recorded them.

DateBranchAction
2019-01-22HouseReferred to the committee on Mental Health, Substance Use and Recovery
2019-01-22SenateSenate concurred
2019-09-16JointHearing scheduled for 09/19/2019 from 10:00 AM-01:00 PM in B-1
2020-03-09HouseAccompanied a new draft, see H4532

Public hearing

House Rule 27 counts its reporting deadline from the day a bill is heard.

DateCommitteeWhereStatus
2019-09-19Mental Health, Substance Use and Recovery (J)B-1, 24 Beacon Street, BostonCompleted

Committee actions

ActionCommittee
AccompaniedMental Health, Substance Use and Recovery (J)

Cosponsors

In the order filed.

Every action here is as the legislature published it. A bill that drew no recorded vote is the ordinary case: the House records roughly 150 a year.